Tower Research Capital (TRC)’s Adagene ADAG Stock Holding History
Bought
Maintained
Sold
Other funds holding ADAG
SL
DIG
Tower Research Capital (TRC)'s ADAG Position: Q3 2026 in Review
Tower Research Capital (TRC) sold out of Adagene (ADAG) in Q3 2026, closing a stake of 1,058 shares — an estimated $4.44K sold.
Tower Research Capital (TRC) first reported a position in ADAG in Q4 2021 and held it in 4 quarters. The position peaked at $17K in Q1 2022. 38 funds tracked by Wall St. Rank hold ADAG as of Q3 2026.
- Tower Research Capital (TRC) reported no remaining Adagene position as of Q3 2026 after selling out during the quarter.
- Tower Research Capital (TRC) sold 1,058 Adagene shares in Q3 2026, an estimated $4.44K.
- Tower Research Capital (TRC) first reported a position in Adagene in Q4 2021 and held it in 4 quarters.
- Tower Research Capital (TRC)'s Adagene position peaked at $17K in Q1 2022.
- 38 funds tracked by Wall St. Rank held Adagene as of Q3 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.